Clinical Trial Update: A Study Of The Safety And Effects Of One Or More Doses Of HSP-130 Injected Under The Skin In Women With Breast Cancer That Has Not Spread To Distant Sites In The Body. [Phase 2]

View source ↗

Summary

Phase II trial assessing safety and effects of HSP-130 injected under the skin in women with non-metastatic breast cancer; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HSP-130

Snippet

Sponsor: Pfizer | Conditions: Non-metastatic Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-10-23